Table 4.
Adverse event | Grade 1 | Grade 2 | Grade 3 | Grade 4 |
---|---|---|---|---|
Hematologic | ||||
Anemia | 8 | 0 | 0 | 0 |
Leucopenia | 1 | 6 | 1 | 0 |
Neutropenia | 1 | 0 | 6 | 0 |
Lymphopenia | 1 | 4 | 4 | 0 |
Thrombocytopenia | 13 | 2 | 0 | 0 |
Nonhematologic | ||||
Ventricular arrhythmia | 1 | 0 | 0 | 0 |
Cardiac general | 0 | 0 | 1 | 0 |
Hypotension | 0 | 0 | 1 | 0 |
PT prolongation | 1 | 0 | 0 | 0 |
Fatigue | 7 | 6 | 3 | 1 |
Fever without neutropenia | 1 | 0 | 0 | 0 |
Weight loss | 1 | 0 | 0 | 0 |
Alopecia | 1 | 0 | 0 | 0 |
Dry skin | 1 | 0 | 0 | 0 |
Injection site reaction | 0 | 0 | 1 | 0 |
Pruritis | 0 | 1 | 0 | 0 |
Skin rash | 2 | 0 | 1 | 0 |
Anorexia | 4 | 0 | 0 | 0 |
Constipation | 6 | 0 | 1 | 0 |
Diarrhea | 3 | 1 | 0 | 0 |
Dry mouth | 1 | 0 | 0 | 0 |
Flatulence | 0 | 1 | 0 | 0 |
Heartburn | 1 | 1 | 0 | 0 |
Mucositis | 0 | 1 | 0 | 0 |
Nausea | 11 | 2 | 0 | 0 |
Taste alteration | 1 | 0 | 0 | 0 |
Vomiting | 1 | 1 | 1 | 0 |
Petechiae | 1 | 0 | 0 | 0 |
Edema–limb | 1 | 1 | 0 | 0 |
ALT elevation | 7 | 0 | 1 | 0 |
AST elevation | 0 | 1 | 0 | 0 |
Alkaline phosphatase elevation | 1 | 0 | 0 | 0 |
Bilirubin elevation | 0 | 1 | 0 | 0 |
Cholesterol elevation | 0 | 1 | 0 | 0 |
Creatinine elevation | 1 | 0 | 0 | 0 |
Hyperglycemia | 1 | 3 | 0 | 0 |
Hypermagnesemia | 1 | 0 | 0 | 0 |
Hypoalbuminemia | 1 | 0 | 0 | 0 |
Hypocalcemia | 2 | 0 | 0 | 0 |
Hypokalemia | 3 | 0 | 0 | 0 |
Hypomagnesemia | 1 | 0 | 0 | 0 |
Hyponatremia | 1 | 0 | 0 | 0 |
Hypophosphatemia | 2 | 2 | 1 | 0 |
Muscle weakness (lower extremity) | 0 | 2 | 0 | 0 |
Muscle weakness (whole body) | 0 | 1 | 0 | 0 |
Extremity-upper (function) | 0 | 1 | 0 | 0 |
Joint–function | 1 | 0 | 0 | 0 |
Confusion | 1 | 0 | 0 | 0 |
Dizziness | 1 | 2 | 0 | 0 |
Blurred vision | 1 | 0 | 0 | 0 |
Abdominal pain | 3 | 0 | 0 | 0 |
Chest/thorax pain | 1 | 0 | 0 | 0 |
Limb pain | 1 | 0 | 0 | 0 |
Headache | 0 | 1 | 0 | 0 |
Joint pain | 2 | 1 | 0 | 0 |
Thrombosis or embolism of vascular access | 0 | 0 | 0 | 1 |
ALT, alanine aminotransferse; AST, aspartate aminotransferase; and PT, prothrombin time.